Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros

Métodos Terapéuticos y Terapias MTCI
Bases de datos
País/Región como asunto
Tipo del documento
Intervalo de año de publicación
1.
Early Interv Psychiatry ; 15(1): 123-132, 2021 02.
Artículo en Inglés | MEDLINE | ID: mdl-31975541

RESUMEN

AIM: The First Episode Mood and Anxiety Program (FEMAP) is a community-based early intervention program that has been shown to improve health outcomes for emerging adults (EAs) with mood and anxiety disorders. However, not all EAs who are admitted to the program initiate treatment. Our aim was to identify factors that distinguish those who initiated treatment from those who did not. METHODS: FEMAP administered questionnaires to EAs upon first contact with the program, collecting information on a range of socioeconomic, patient and condition-related factors. We compared EAs who initiated treatment in the program (n = 318, 87.4%) to those who did not (n = 46, 12.6%). To examine factors associated with treatment initiation, we specified a parsimonious logistic regression model, using the method of purposeful selection to choose from a range of candidate variables. RESULTS: Anxiety Sensitivity Index - Revised (ASI-R), binge drinking and cannabis use were included in the final logistic regression model. Each one-point increment in the ASI-R score was associated with a 1% increase in the odds of treatment initiation (OR = 1.014; 95% CI [1.003, 1.026]). No other variable was significantly associated with treatment initiation. CONCLUSIONS: Our study provides insight on the differences between EAs with mood and anxiety disorders who initiated targeted treatment services and those who did not. Anxiety sensitivity was significantly associated with treatment initiation at FEMAP. Our findings suggest that it may be anxiety sensitivity, rather than depression or functional impairment per se that drive treatment initiation among EAs.


Asunto(s)
Trastornos de Ansiedad , Ansiedad , Adulto , Afecto , Trastornos de Ansiedad/terapia , Humanos , Trastornos del Humor/tratamiento farmacológico , Encuestas y Cuestionarios
2.
Int J Adolesc Med Health ; 25(3): 309-14, 2013.
Artículo en Inglés | MEDLINE | ID: mdl-23839811

RESUMEN

Cannabis use is common in youth and there is evidence that the co-occurrence of cannabis use (and other substance use) with mental illnesses predicts poorer outcomes, including suicide. The main purposes of this study were to: (i) identify rates of cannabis use and substance use disorder risk, and (ii) predictors for cannabis use among youth seeking help for mood and/or anxiety concerns in a sample population prescreened to exclude primary substance use disorders; and (iii) to determine if there was an association between cannabis use and functional impairment in this sample. We investigated substance use risk as well as hypothesized predictors of cannabis use and functional impairment including demographic characteristics, socioeconomic status, trait coping style, age of onset of several risk behaviors, current use of common addictive substances, level of functional impairment, and current psychiatric symptom severity. Results showed that approximately half of the participants were at moderate to high risk for a substance use disorder, and just over 4% appeared to have a primary substance use disorder. They also suggested an association between cannabis use and gender (male), age of first cannabis use, recent cigarette use, and functional impairment. Independently, functional impairment was predicted by inattentive coping style, depression severity, and total cannabis use score. These results confirm a high risk for addictive disorders and an association between cannabis use and functional impairment in this sample. These results support the need for substance use treatment programs to optimize care wherever youth with primary mood and/or anxiety concerns are seen.


Asunto(s)
Trastornos de Ansiedad , Abuso de Marihuana , Trastornos del Humor , Prevención del Suicidio , Suicidio , Actividades Cotidianas/psicología , Adolescente , Conducta del Adolescente , Adulto , Edad de Inicio , Trastornos de Ansiedad/epidemiología , Trastornos de Ansiedad/psicología , Canadá/epidemiología , Diagnóstico Dual (Psiquiatría) , Evaluación de la Discapacidad , Femenino , Necesidades y Demandas de Servicios de Salud , Humanos , Masculino , Abuso de Marihuana/complicaciones , Abuso de Marihuana/epidemiología , Abuso de Marihuana/prevención & control , Abuso de Marihuana/psicología , Trastornos del Humor/epidemiología , Trastornos del Humor/psicología , Aceptación de la Atención de Salud/psicología , Prevalencia , Escalas de Valoración Psiquiátrica , Medición de Riesgo/métodos , Factores de Riesgo , Factores Sexuales , Suicidio/psicología
3.
J Altern Complement Med ; 10 Suppl 1: S211-21, 2004.
Artículo en Inglés | MEDLINE | ID: mdl-15630838

RESUMEN

This paper presents a research agenda for the use of optimal healing environments (OHEs) for the treatment (and possible prevention) of the negative effects of exposure to extreme environmental stress or trauma. As background for understanding, this paper starts by briefly introducing the unique perspective of psychiatry in the field of OHEs. It then describes the nature of trauma spectrum responses including the best-known psychiatric response, post-traumatic stress disorder (PTSD), a description of the current accepted treatments for PTSD, and the status of research in alternative and complementary treatments for PTSD. These are followed by a discussion of the emerging role of clinical neurobiology in mental health, specifically the potential for the use of neuroimaging in filling a gap in methods of evaluating OHEs in trauma research. Last, it provides a list of important potential topics of research within the fields of trauma responses, neuroscience and OHEs.


Asunto(s)
Terapias Complementarias/normas , Neurobiología/normas , Atención Dirigida al Paciente/normas , Trastornos por Estrés Postraumático/terapia , Encéfalo/fisiopatología , Terapias Complementarias/métodos , Prestación Integrada de Atención de Salud/normas , Salud Holística , Humanos , Acontecimientos que Cambian la Vida , Relaciones Metafisicas Mente-Cuerpo , Proyectos de Investigación , Factores de Riesgo , Trastornos por Estrés Postraumático/prevención & control , Estrés Psicológico/etiología , Estrés Psicológico/terapia , Estados Unidos
4.
Psychiatry ; 67(4): 353-83, 2004.
Artículo en Inglés | MEDLINE | ID: mdl-15801377

RESUMEN

Stress, especially the extreme stress of traumatic events, can alter both neurobiology and behavior. Such extreme environmental situations provide a useful model for understanding environmental influences on human biology and behavior. This paper will review some of the evidence of brain alterations that occur with exposure to environmental stress. This will include recent studies using neuroimaging and will address the need for histological confirmation of imaging study results. We will review the current scientific approaches to understanding brain environment interactions, and then make the case for the collection and study of postmortem brain tissue for the advancement of our understanding of the effects of environment on the brain. Creating a brain tissue collection specifically for the investigation of the effects of extreme environmental stressors fills a gap in the current research; it will provide another of the important pieces to the puzzle that constitutes the scientific investigation of negative effects of environmental exposures. Such a resource will facilitate new discoveries related to the psychiatric illnesses of acute stress disorder and posttraumatic stress disorder, and can enable scientists to correlate structural and functional imaging findings with tissue abnormalities, which is essential to validate the results of recent imaging studies.


Asunto(s)
Encéfalo/patología , Encéfalo/fisiopatología , Ambiente , Trastornos por Estrés Postraumático/fisiopatología , Trastornos por Estrés Postraumático/psicología , Trastornos de Estrés Traumático Agudo/fisiopatología , Trastornos de Estrés Traumático Agudo/psicología , Bancos de Tejidos , Estimulación Acústica/efectos adversos , Axones/fisiología , Encéfalo/metabolismo , Epinefrina/sangre , Epinefrina/orina , Humanos , Sistema Límbico/anatomía & histología , Sistema Límbico/metabolismo , Sistema Límbico/patología , Sistema Límbico/fisiopatología , Norepinefrina/sangre , Norepinefrina/orina , Reflejo de Sobresalto , Trastornos por Estrés Postraumático/metabolismo , Trastornos de Estrés Traumático Agudo/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA